Literature DB >> 15985994

[Occurrence of synchronous colorectal cancer metastasis in the cirrhotic or fatty liver].

C Iascone1, M Ruperto, P Barillari.   

Abstract

AIM: Metastases from colorectal cancers rarely occur in injured livers, however this phenomenon has not been fully investigated in patients with different degree of liver damage. Therefore in this study we evaluated the incidence of synchronous hepatic metastases in patients with fatty or cirrhotic liver submitted to surgery for colorectal neoplasms.
METHODS: Seven hundred and forty-seven patients undergoing surgical treatment for colorectal neoplasms were evaluated: the clinicopathological data of 171 patients with liver cirrhosis and 33 with fatty liver were compared to those of 543 patients without liver damage.
RESULTS: Gender, age, type of operative procedures performed and histological grading were similar in patients with or without liver damage. In patients with liver cirrhosis the incidence of stage II tumour was greater, while stage IV tumours (P < 0.001) and nodal involvement were significantly lower than in patients with non injured or fatty liver (P < 0.02 and P < 0.001 respectively) . At the time of surgery, synchronous hepatic metastases were present in 32% of patients with normal liver, in 15% of patients with fatty liver (P < 0.02) and in 4.7% of patients with liver cirrhosis (P < 0.001).
CONCLUSIONS: Results of our study show that synchronous hepatic metastases of colorectal cancer are less frequently observed in patients with fatty or cirrhotic liver than in patients with non injured liver, indicating that chronically damaged livers are protected from the spread of secondary cancers.

Entities:  

Mesh:

Year:  2005        PMID: 15985994

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  6 in total

1.  Multicentre study of liver metastases from colorectal cancer in pathological livers.

Authors:  Jose M Ramia; Rafael López-Andujar; Jaume Torras; Laia Falgueras; Jose Antonio Gonzalez; Belinda Sanchez; Joan Figueras
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

Review 2.  Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection.

Authors:  Rafif E Mattar; Faisal Al-Alem; Eve Simoneau; Mazen Hassanain
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

3.  Patients with chronically diseased livers have lower incidence of colorectal liver metastases: a meta-analysis.

Authors:  Bin Cai; Kai Liao; Xian-qing Song; Wei-yuan Wei; Yuan Zhuang; Sen Zhang
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

4.  Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients.

Authors:  Giulia Besutti; Angela Damato; Francesco Venturelli; Candida Bonelli; Massimo Vicentini; Filippo Monelli; Pamela Mancuso; Guido Ligabue; Pierpaolo Pattacini; Carmine Pinto; Paolo Giorgi Rossi
Journal:  BMC Cancer       Date:  2021-03-09       Impact factor: 4.430

Review 5.  The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Filippo Monelli; Giulia Besutti; Olivera Djuric; Laura Bonvicini; Roberto Farì; Stefano Bonfatti; Guido Ligabue; Maria Chiara Bassi; Angela Damato; Candida Bonelli; Carmine Pinto; Pierpaolo Pattacini; Paolo Giorgi Rossi
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

6.  Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation.

Authors:  Lipeng Cheng; Li Geng; Binghua Dai; Tao Zheng; Jun Fu; Liang Qiao; Wenchang Cai; Yue Wang; Jiamei Yang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.